Beta-Blocker Interruption or Continuation after Myocardial Infarction
New England Journal of Medicine · 10.10.2024 · 391 (14) · 1277-1286
DOI: 10.1056/nejmoa2404204 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift New England Journal of Medicine, erschienen am 10.10.2024. Verfasst von Johanne Silvain und 36 weiteren Autor:innen. Beteiligte Einrichtung: From Sorbonne Université, ACTION Group, INSERM Unité Mixte de Recherche (UMRS) 1166, Hôpital Pitié-Salpêtrière Assistance Publique-Hôpitaux de Paris …. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Myocardial Infarction, Quality of Life, Secondary Prevention. Die Arbeit wurde bisher 165-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Ministère de la Santé, French Ministry of Health, ACTION.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- From Sorbonne Université, ACTION Group, INSERM Unité Mixte de Recherche (UMRS) 1166, Hôpital Pitié-Salpêtrière Assistance Publique-Hôpitaux de Paris (AP-HP) (J.S., P.G., N.P., K.A., G.M.), the Department of Cardiology,…
ORCID-Profile: Johanne Silvain, Christophe Thuaire, Pierre Deharo
Förderung
- Ministère de la Santé
- French Ministry of Health
- ACTION
Zitieren
APA
Silvain, J., Cayla, G., Ferrari, E., Range, G., Puymirat, E., Delarche, N., Guedeney, P., Cuisset, T., Ivanes, F., Lhermusier, T., Petroni, T., Lemesle, G., Bresoles, F., Labeque, J. N., Pommier, T., Dillinger, J. G., Leclercq, F., Boccara, F., Lim, P., …, & ABYSS Investigators of the ACTION Study Group (2024). Beta-Blocker Interruption or Continuation after Myocardial Infarction. New England Journal of Medicine, 391(14), 1277-1286. https://doi.org/10.1056/nejmoa2404204
Vancouver
Silvain J, Cayla G, Ferrari E, Range G, Puymirat E, Delarche N, et al. Beta-Blocker Interruption or Continuation after Myocardial Infarction. New England Journal of Medicine. 2024;391(14):1277-1286. doi:10.1056/nejmoa2404204
BibTeX
@article{Silvain2024,
author = {Silvain, Johanne and Cayla, Guillaume and Ferrari, Emile and Range, Grégoire and Puymirat, Etienne and Delarche, Nicolas and Guedeney, Paul and Cuisset, Thomas and Ivanes, Fabrice and Lhermusier, Thibault and Petroni, Thibault and Lemesle, Gilles and Bresoles, François and Labeque, Jean-Noël and Pommier, Thibaut and Dillinger, Jean-Guillaume and Leclercq, Florence and Boccara, Franck and Lim, Pascal and Besseyre des Horts, Timothée and Fourme, Thierry and Jourda, François and Furber, Alain and Lattuca, Benoit and Redjimi, Nassim and Thuaire, Christophe and Deharo, Pierre and Procopi, Niki and Dumaine, Raphaelle and Slama, Michel and Payot, Laurent and El Kasty, Mohamad and Aacha, Karim and Diallo, Abdourahmane and Vicaut, Eric and Montalescot, Gilles and ABYSS Investigators of the ACTION Study Group, ABYSS Investigators of the ACTION Study Group},
title = {Beta-Blocker Interruption or Continuation after Myocardial Infarction},
journal = {New England Journal of Medicine},
year = {2024},
volume = {391},
number = {14},
pages = {1277--1286},
doi = {10.1056/nejmoa2404204}
}
EUVIMED